PK

Pramod Kumar

Active Director Director DIN 09567374
DIN 09567374 First appointment Apr 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Pramod Kumar

Data last updated:

Pramod Kumar is a Director at Adlec Pharma Private Limited (since 2022). The company operates in Chemicals. Adlec Pharma Private Limited reported revenue of ₹5.3 Lakh (FY 2025).

DIN 09567374
Primary Designation Director
Industry Chemicals
First Appointment 09 Apr 2022
Oldest Company Age 4 yrs
Largest company Adlec Pharma Private Limited · ₹5.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Adlec Pharma Private Limited U24230UP2022PTC162162
Director09 Apr 20222022₹5.3 Lakh (FY 2025)Active

Board colleagues of Pramod Kumar

NameDINCompanyDesignation
Nitin Panwar09567373Adlec Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Adlec Pharma Private Limited
Premium access

Shareholding and investment profile for Pramod Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pramod Kumar

Pramod Kumar currently holds 1 directorship: Adlec Pharma Private Limited (Director, since 09 Apr 2022, revenue ₹5.3 Lakh (FY 2025)).

Pramod Kumar was first appointed on 09 Apr 2022 as Director at Adlec Pharma Private Limited.

The current boards of Pramod Kumar's companies include Nitin Panwar (Adlec Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available